Starling Oncology (STLNW) Net Cash Flow Growth (3y) (2023 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.89 Bn | 11.20 Bn | 1.16 Bn | 60.86% |
| 2 | RadNet | 5.51 Bn | 4.78 Bn | 88.08 Mn | 0.61% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | -46.15% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | - |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | -45.66% |
| 6 | Pediatrix Medical | 2.14 Bn | 1.74 Bn | - | 572.53% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 11.40% |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn | 35.81% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn | -26.57% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | -7.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.45% |
| Mar 31, 2026 | -66.90% |
| Dec 31, 2025 | 28.56% |
| Sep 30, 2025 | 1.82% |
| Jun 30, 2025 | 32.94% |
| Mar 31, 2025 | 20.33% |
| Dec 31, 2024 | -72.82% |
| Sep 30, 2024 | 71.21% |
| Jun 30, 2024 | 26.62% |
| Mar 31, 2024 | -50.69% |
| Dec 31, 2023 | 32.17% |
| Sep 30, 2023 | -135.02% |
| Jun 30, 2023 | 229.40% |